Furthermore, deletion of the tumor necrosis factor receptor 1 (TNFR1) gene in transgenic AD mice showed decreased Aβ generation, plaque burden, BACE-1 expression, and cognitive deficits [55]. This evidence concerns the gene TNFRSF1A and Alzheimer disease.